InvestorsHub Logo
Followers 59
Posts 7368
Boards Moderated 0
Alias Born 10/20/2014

Re: Whalatane post# 386144

Friday, 08/12/2022 8:15:48 PM

Friday, August 12, 2022 8:15:48 PM

Post# of 423977
If such a one day formulation could be launched and be indicated for CVD...
at a cost less than GV...that would indeed be a game changer. My opinion
would remain that it would still have to be owned by BP in order to optimize
sales and "rebrand" the drug in a positive way that BP is very good at.
I do not have a great deal of faith that KM would be able to accomplish
this even if it were possible. Ideally, BP will acquire AMRN long before then so
we never have to find out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News